Comparative analysis of renal protein expression in spontaneously hypertensive rat

Clinical and Experimental Hypertension

Volumn 30, Issue 5, 2008, Pages 315-325

  Yu, Min ^a   Wang, Xingxiang ^a   Du, Yuxi ^b   Chen, Hongjuan ^a   Guo, Xiaogang ^a   Xia, Liang ^a   Chen, Junzhu ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Essential hypertension; Mass spectrometry; Spontaneously hypertensive rats; Two dimensional gel electrophoresis

Indexed keywords

ALDOKETO REDUCTASE FAMILY 1 MEMBER A1 PROTEIN; ISOCITRATE DEHYDROGENASE (NADP); LAMININ GAMMA 2 CHAIN PRECURSOR; PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN S2; TCRB PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; ESSENTIAL HYPERTENSION; LIPID TRANSPORT; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WISTAR KYOTO RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIOLES; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; HYPERTENSION; ISOCITRATE DEHYDROGENASE; KIDNEY; LOSARTAN; MALE; MASS SPECTROMETRY; NEPHROSCLEROSIS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; UP-REGULATION;

EID: 47549111526     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802269935     Document Type: Article

References (35)

1. Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet 2003;361:1629-1641.
2. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348:101-108.
3. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end stage renal disease in men. N Engl J Med 1996;334:13-18.
4. De Leeuw PW, Thijs L, Birkenhager WH, Voyaki SM, Efstratopoulos AD, Fagard RH, Leonetti G, Nachev C, Petrie JC, Rodicio JL, Rosenfeld JJ, Sarti C, Staessen JA. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: Results from the Syst-Eur trial. J Am Soc Nephrol 2002;13:2218-2222.
5. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. Hypertension 1989;13(Suppl. 1):80-93.
6. Frohlich ED, Arthur C. Corcoran Memorial Lecture. Influence of nitric oxide and angiotensin-II on renal involvement in hypertension. Hypertension 1997;29:188-193.
7. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
8. Mulrow PJ. The intrarenal renin-angiotensin system. Curr Opin Nephrol Hypertens 1993;2:41-44.
9. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001;104:545-556.
10. Thongboonkerd V, Gozal E, Sachleben LR, Arthur JM, Pierce WM, Cai J, Chao J, Bader M, Pesquero JB, Gozal D, Klein JB. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem 2002;277:34708-34716.
11. Pinet F, Poirier F, Fuchs S, Tharaux PL, Caron M, Corvol P, Michel JB, Joubert-Caron R. Troponin T as a marker of differentiation revealed by proteomic analysis in renal arterioles. FASEB 2004;18:585-586.
12. Zhou SG, Zhou SF, Huang HQ, Chen JW, Huang M, Liu PQ. Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats. J Proteome Res 2006;5:2901-2908.
13. Gallego-Delgado J, Lazaro A, Osende JI, Barderas MG, Duran MC, Vivanco F, Egido JJ. Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. J Proteome Res 2006;5:404-413.
14. Gallego-Delgado J, Lazaro A, Osende JI, Esteban V, Barderas MG, Gomez-Guerrero C, Vega R, Vivanco F, Egido J. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: Modulation by antihypertensive therapies. J Am Soc Nephrol 2006;17:S159-S164.
15. Jin X, Xia L, Wang LS, Shi JZ, Zheng Y, Chen WL, Zhang L, Liu ZG, Chen GQ, Fang NY. Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics 2006;6:1948-1956.
16. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002;39:269-274.
17. Bowers MC, Katki KA, Rao A, Koehler M, Patel P, Spiekerman A, DiPette DJ, Supowit SC. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension 2005;46:51-57.
18. Janech MG, Raymond JR, Arthur JM. Proteomics in renal research. Am J Physiol Renal Physiol. 2007;292:F501-F512.
19. Yamamoto T, Hayashi K, Matsuda H, Kubota E, Tanaka H, Ogasawara Y, Nakamoto H, Suzuki H, Saruta T, Kajiya F. In vivo visualization of angiotensin II and tubuloglomerular feedback-mediated renal vasoconstriction. Kidney Int 2001;60:364-369.
20. Zhao WN, Lee MH. Assembly and function of a cytosolic form of NADH-specific isocitrate dehydrogenasein yeast. J Biol Chem 1996;271:10347-10352.
21. +-dependent isocitrate dehydrogenase in kidney and heart of rat: An immunocytochemical and biochemical study. J Histochem Cytochem 2003;51:215-226.
22. +-dependent isocitrate dehydrogenase. J Biol Chem 2001;276:16168-16176.
23. +-dependent isocitrate dehydrogenase. J Biol Chem 2007;282:13385-13394.
24. +-dependent isocitrate dehydrogenase protects cadmium-induced apoptosis. Mol Pharmacol 2006;70:1053-1061.
25. +-dependent isocitrate dehydrogenase. Free Radic Biol Med 2006;40:110-119.
26. Lee JH, Park JW. Oxalomalate regulates ionizing radiation-induced apoptosis in mice. Free Radic Biol Med 2007;42:44-51.
27. +-isocitrate. dehydrogenase activity and expression: A marker of oxidative stress in hypertrophy development. Am J Physiol Heart Circ Physiol 2004;287:H2122-H2131.
28. +-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: An event that precedes hypertrophy development. J Biol Chem 2003;278:45154-45159.
29. +-dependent isolated dehydrogenase by nitric oxide. Free Radic Biol Med. 2002;33:927-937.
30. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998;101:1530-1537.
31. Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, Münzel T. Effects of angiotensin II infusion on the expression and function of NADPH oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:E58-E65.
32. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NADPH oxidase activity: Upstream mediators. Circ Res 2002;91:406-413.
33. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004;4:3665-3685.
34. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression: A challenge for proteomic research. Electrophoresis 2000;21:1104-1115.
35. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains. Proteomics 2002;2:3-10.